Dai ichi Life Insurance Company Ltd Sells 58,159 Shares of Xylem Inc. (NYSE:XYL)

Dai ichi Life Insurance Company Ltd decreased its holdings in Xylem Inc. (NYSE:XYL) by 74.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,194 shares of the industrial products company’s stock after selling 58,159 shares during the period. Dai ichi Life Insurance Company Ltd’s holdings in Xylem were worth $2,727,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Swedbank AB lifted its stake in Xylem by 22.8% in the third quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock worth $403,953,000 after purchasing an additional 554,609 shares during the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of Xylem in the third quarter worth about $52,169,000. Champlain Investment Partners LLC increased its stake in Xylem by 17.8% in the 3rd quarter. Champlain Investment Partners LLC now owns 1,657,785 shares of the industrial products company’s stock worth $223,851,000 after buying an additional 249,975 shares during the period. LPL Financial LLC grew its stake in Xylem by 246.6% in the 2nd quarter. LPL Financial LLC now owns 324,504 shares of the industrial products company’s stock worth $44,012,000 after acquiring an additional 230,878 shares in the last quarter. Finally, TCW Group Inc. raised its stake in shares of Xylem by 189.2% during the second quarter. TCW Group Inc. now owns 315,400 shares of the industrial products company’s stock valued at $42,778,000 after acquiring an additional 206,350 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Price Performance

Shares of NYSE XYL opened at $125.60 on Thursday. Xylem Inc. has a 52 week low of $102.63 and a 52 week high of $146.08. The company has a quick ratio of 1.42, a current ratio of 1.96 and a debt-to-equity ratio of 0.19. The firm has a market cap of $30.51 billion, a P/E ratio of 36.73, a P/E/G ratio of 2.29 and a beta of 1.05. The business’s 50 day moving average price is $129.89 and its 200 day moving average price is $134.00.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting the consensus estimate of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The company had revenue of $2.10 billion during the quarter, compared to analysts’ expectations of $2.17 billion. During the same period last year, the business earned $0.99 earnings per share. Xylem’s quarterly revenue was up .2% on a year-over-year basis. On average, sell-side analysts expect that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 24th. Investors of record on Tuesday, November 26th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a yield of 1.15%. Xylem’s dividend payout ratio is currently 42.11%.

Wall Street Analyst Weigh In

Several research analysts have commented on XYL shares. TD Cowen reduced their price objective on Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a report on Wednesday, November 6th. Stifel Nicolaus lifted their price objective on Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a report on Wednesday, July 31st. Robert W. Baird dropped their target price on shares of Xylem from $175.00 to $154.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Royal Bank of Canada reduced their price target on shares of Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Finally, UBS Group assumed coverage on shares of Xylem in a research note on Tuesday, August 13th. They set a “buy” rating and a $165.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $149.64.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.